Sign in
4

Changes in Ownership

Spero Therapeutics, Inc. Filed Acc 0001193125-26-038184

See Remarks sold 18,442 shares at $2.20 ($40,572)

  • See Remarks acquired 249,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rajavelu Esther See Remarks 2026-02-02 Grant or award +249,000 1,118,450 D
Rajavelu Esther See Remarks 2026-02-02 Sale −18,442 $2.20 $40,572 1,100,008 D
Derivatives
Rajavelu Esther See Remarks 2026-02-02 Grant or award · Stock Option (Right to Buy) +498,000 498,000 D
Open-market sales · 18,442 sh · avg $2.20 · $40,572
Loading xslF345X05/ownership.xml…